Home » Topics » Regulatory

Regulatory
RSS

FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma

May 19, 2017

European Commission approves dinutuximab beta for the treatment of high-risk neuroblastoma

May 11, 2017

FDA approves Bavencio for advanced urothelial carcinoma

May 10, 2017

FDA approves Kisqali Femara Co-Pack

May 10, 2017

FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture

May 3, 2017

FDA grants accelerated approval to Alunbrig for ALK-positive NSCLC

May 2, 2017

FDA approves Rydapt for patients with newly diagnosed AML with FLT3 mutation

May 2, 2017

FDA grants accelerated approval to Imfinzi for previously treated bladder cancer

May 2, 2017

FDA approves Stivarga for second-line treatment of hepatocellular carcinoma

April 28, 2017

FDA approves Brineura to treat CLN2 disease

April 28, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...